Insight-Led Launch Strategy for a First-in-Class Immune Therapy

Our Challenge: A global immunology team preparing to launch a novel therapy needed a strategic understanding of where and how the product could win. Early vendor research left major gaps: rheumatologists' categorization of patients was inconsistent, demand moments were unclear, and competing mechanisms were entering the market ahead of them. With a competitor launching first, the team needed a behaviorally grounded strategy that identified high-value patient segments, clarified how physicians actually make sequencing decisions, and translated these drivers into concrete launch opportunities. 

Our Unique Approach: We built a launch strategy blueprint based on critical behavioral insights we uncovered. We synthesized findings across markets to map the real decision patterns shaping treatment choice, then translated these insights into strategic opportunities across positioning, evidence, access, and early-adopter activation. This gave the team a unified narrative explaining where the treatment fits, when it should compete, and where the key demand moments would be within the competitor landscape. 

Successful Outcomes: We delivered a cohesive launch opportunity framework outlining 5 high-leverage areas including strategic messaging, functional-impact tools, country-specific access levers, an R&D evidence agenda, and leading and lagging KPIs.